Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease

Movement Disorders

Volumn 30, Issue 4, 2015, Pages 472-483

  Matsumoto, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cognitive dysfunction; Dopamine neuron; Parkinson's disease; Reward; Salience

Indexed keywords

DOPAMINE;

COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; HUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; REWARD; SIGNAL TRANSDUCTION; THEORY; ANIMAL; COGNITION DISORDERS; COMPLICATION; METABOLISM; PHYSIOLOGY;

ANIMALS; COGNITION DISORDERS; DOPAMINE; HUMANS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 84926154289     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26177     Document Type: Review

References (134)

1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
2. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 2002;67:53-83.
3. Bradley VA, Welch JL, Dick DJ. Visuospatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:1228-1235.
4. Owen AM, Iddon JL, Hodges JR, Summers BA, Robbins TW. Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia 1997;35:519-532.
5. Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 2004;24:702-710.
6. Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R. Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions. Brain 2002;125:276-289.
7. Gauggel S, Rieger M, Feghoff TA. Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:539-544.
8. Bokura H, Yamaguchi S, Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 2005;43:967-975.
9. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115:1727-1751.
10. Canavan AG, Passingham RE, Marsden CD, Quinn N, Wyke M, Polkey CE. The performance on learning tasks of patients in the early stages of Parkinson's disease. Neuropsychologia 1989;27:141-156.
11. Narayanan NS, Rodnitzky RL, Uc EY. Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Rev Neurosci 2013;24:267-278.
12. Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008;131:1294-1302.
13. Bayer HM, Glimcher PW. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron 2005;47:129-141.
14. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998;80:1-27.
15. Morris G, Arkadir D, Nevet A, Vaadia E, Bergman H. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 2004;43:133-143.
16. Nakahara H, Itoh H, Kawagoe R, Takikawa Y, Hikosaka O. Dopamine neurons can represent context-dependent prediction error. Neuron 2004;41:269-280.
17. Satoh T, Nakai S, Sato T, Kimura M. Correlated coding of motivation and outcome of decision by dopamine neurons. J Neurosci 2003;23:9913-9923.
18. Doya K. Metalearning and neuromodulation. Neural Netw 2002;15:495-506.
19. Montague PR, Dayan P, Sejnowski TJ. A framework for mesencephalic dopamine systems based on predictive Hebbian learning. J Neurosci 1996;16:1936-1947.
20. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997;275:1593-1599.
21. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998;28:309-369.
22. Shohamy D, Myers CE, Grossman S, Sage J, Gluck MA, Poldrack RA. Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. Brain 2004;127:851-859.
23. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257.
24. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.
25. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010;68:815-834.
26. Matsumoto M, Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 2009;459:837-841.
27. Matsumoto M, Takada M. Distinct representations of cognitive and motivational signals in midbrain dopamine neurons. Neuron 2013;79:1011-1024.
28. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707; quiz 1837.
29. Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
30. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
31. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW. Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:757-766.
32. Dagher A, Owen AM, Boecker H, Brooks DJ. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 2001;124:1020-1032.
33. Ransmayr G, Schmidhuber-Eiler B, Karamat E, Engler-Plorer S, Poewe W, Leidlmair K. Visuoperception and visuospatial and visuorotational performance in Parkinson's disease. J Neurol 1987;235:99-101.
34. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
35. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain 1992;115:1701-1725.
36. Gotham AM, Brown RG, Marsden CD. Levodopa treatment may benefit or impair "frontal" function in Parkinson's disease. Lancet 1986;2:970-971.
37. Watanabe M, Kodama T, Hikosaka K. Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J Neurophysiol 1997;78:2795-2798.
38. Li BM, Mei ZT. Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav Neural Biol 1994;62:134-139.
39. Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991;251:947-950.
40. Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 1994;71:515-528.
41. Tobler PN, Fiorillo CD, Schultz W. Adaptive coding of reward value by dopamine neurons. Science 2005;307:1642-1645.
42. Fiorillo CD, Newsome WT, Schultz W. The temporal precision of reward prediction in dopamine neurons. Nat Neurosci 2008 Jul 27. [Epub ahead of print].
43. Hollerman JR, Schultz W. Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci 1998;1:304-309.
44. Enomoto K, Matsumoto N, Nakai S, et al. Dopamine neurons learn to encode the long-term value of multiple future rewards. Proc Natl Acad Sci U S A 2011;108:15462-15467.
45. D'Ardenne K, McClure SM, Nystrom LE, Cohen JD. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008;319:1264-1267.
46. Bromberg-Martin ES, Hikosaka O. Midbrain dopamine neurons signal preference for advance information about upcoming rewards. Neuron 2009;63:119-126.
47. Cohen JY, Haesler S, Vong L, Lowell BB, Uchida N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 2012;482:85-88.
48. Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998;86:353-387.
49. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
50. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
51. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
52. Kravitz AV, Freeze BS, Parker PR, et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010;466:622-626.
53. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
54. Kreitzer AC, Malenka RC. Striatal plasticity and basal ganglia circuit function. Neuron 2008;60:543-554.
55. Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 2005;17:51-72.
56. Hong S, Hikosaka O. Dopamine-mediated learning and switching in cortico-striatal circuit explain behavioral changes in reinforcement learning. Front Behav Neurosci 2011;5:15.
57. Nakamura K, Hikosaka O. Role of dopamine in the primate caudate nucleus in reward modulation of saccades. J Neurosci 2006;26:5360-5369.
58. Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci 2014;17:1022-1030.
59. Cui G, Jun SB, Jin X, et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 2013;494:238-242.
60. Phillips GD, Salussolia E, Hitchcott PK. Role of the mesoamygdaloid dopamine projection in emotional learning. Psychopharmacology (Berl) 2010;210:303-316.
61. Puig MV, Miller EK. The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning. Neuron 2012;74:874-886.
62. Stamatakis AM, Jennings JH, Ung RL, et al. A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 2013;80:1039-1053.
63. Grace AA, Floresco SB, Goto Y, Lodge DJ. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 2007;30:220-227.
64. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007;30:259-288.
65. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 1984;4:2866-2876.
66. Lodge DJ, Grace AA. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A 2006;103:5167-5172.
67. Mameli-Engvall M, Evrard A, Pons S, et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 2006;50:911-921.
68. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010;35:4-26.
69. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 2007;10:376-384.
70. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997;17:8528-8535.
71. Horvitz JC. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 2000;96:651-656.
72. Redgrave P, Gurney K. The short-latency dopamine signal: a role in discovering novel actions? Nat Rev Neurosci 2006;7:967-975.
73. Ungless MA, Magill PJ, Bolam JP. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 2004;303:2040-2042.
74. Salamone JD. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 1994;61:117-133.
75. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989;52:1655-1658.
76. Thierry AM, Tassin JP, Blanc G, Glowinski J. Selective activation of mesocortical DA system by stress. Nature 1976;263:242-244.
77. Brischoux F, Chakraborty S, Brierley DI, Ungless MA. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci U S A 2009;106:4894-4899.
78. Guarraci FA, Kapp BS. An electrophysiological characterization of ventral tegmental area dopaminergic neurons during differential pavlovian fear conditioning in the awake rabbit. Behav Brain Res 1999;99:169-179.
79. Joshua M, Adler A, Mitelman R, Vaadia E, Bergman H. Midbrain dopaminergic neurons and striatal cholinergic interneurons encode the difference between reward and aversive events at different epochs of probabilistic classical conditioning trials. J Neurosci 2008;28:11673-11684.
80. Carter RM, Macinnes JJ, Huettel SA, Adcock RA. Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses. Front Behav Neurosci 2009;3:21.
81. Koch C, Ullman S. Shifts in selective visual attention: towards the underlying neural circuitry. Hum Neurobiol 1985;4:219-227.
82. Gottlieb JP, Kusunoki M, Goldberg ME. The representation of visual salience in monkey parietal cortex. Nature 1998;391:481-484.
83. Desimone R, Duncan J. Neural mechanisms of selective visual attention. Annu Rev Neurosci 1995;18:193-222.
84. Schultz W. Updating dopamine reward signals. Curr Opin Neurobiol 2013;23:229-238.
85. Fiorillo CD. Two dimensions of value: dopamine neurons represent reward but not aversiveness. Science 2013;341:546-549.
86. Fiorillo CD, Song MR, Yun SR. Multiphasic temporal dynamics in responses of midbrain dopamine neurons to appetitive and aversive stimuli. J Neurosci 2013;33:4710-4725.
87. Fiorillo CD, Yun SR, Song MR. Diversity and homogeneity in responses of midbrain dopamine neurons. J Neurosci 2013;33:4693-4709.
88. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Distinct tonic and phasic anticipatory activity in lateral habenula and dopamine neurons. Neuron 2010;67:144-155.
89. Steinfels GF, Heym J, Strecker RE, Jacobs BL. Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 1983;258:217-228.
90. Horvitz JC, Stewart T, Jacobs BL. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res 1997;759:251-258.
91. Williams SM, Goldman-Rakic PS. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 1998;8:321-345.
92. Porrino LJ, Goldman-Rakic PS. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol 1982;205:63-76.
93. Lynd-Balta E, Haber SN. The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience 1994;59:625-640.
94. Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000;20:2369-2382.
95. Herkenham M, Nauta WJ. Afferent connections of the habenular nuclei in the rat: a horseradish peroxidase study, with a note on the fiber-of-passage problem. J Comp Neurol 1977;173:123-146.
96. Parent A, Gravel S, Boucher R. The origin of forebrain afferents to the habenula in rat, cat and monkey. Brain Res Bull 1981;6:23-38.
97. Herkenham M, Nauta WJ. Efferent connections of the habenular nuclei in the rat. J Comp Neurol 1979;187:19-47.
98. Christoph GR, Leonzio RJ, Wilcox KS. Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J Neurosci 1986;6:613-619.
99. Matsumoto M, Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007;447:1111-1115.
100. Matsumoto M, Hikosaka O. Representation of negative motivational value in the primate lateral habenula. Nat Neurosci 2009;12:77-84.
101. Lin SC, Nicolelis MA. Neuronal ensemble bursting in the basal forebrain encodes salience irrespective of valence. Neuron 2008;59:138-149.
102. Richardson RT, DeLong MR. Electrophysiological studies of the functions of the nucleus basalis in primates. Adv Exp Med Biol 1991;295:233-252.
103. Goldberg ME, Wurtz RH. Activity of superior colliculus in behaving monkey. II. Effect of attention on neuronal responses. J Neurophysiol 1972;35:560-574.
104. Dommett E, Coizet V, Blaha CD, et al. How visual stimuli activate dopaminergic neurons at short latency. Science 2005;307:1476-1479.
105. Coizet V, Dommett EJ, Redgrave P, Overton PG. Nociceptive responses of midbrain dopaminergic neurones are modulated by the superior colliculus in the rat. Neuroscience 2006;139:1479-1493.
106. Holland PC, Gallagher M. Amygdala circuitry in attentional and representational processes. Trends Cogn Sci 1999;3:65-73.
107. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
108. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448.
109. Murty VP, Shermohammed M, Smith DV, Carter RM, Huettel SA, Adcock RA. Resting state networks distinguish human ventral tegmental area from substantia nigra. Neuroimage 2014;100:580-589.
110. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
111. Cools R. Dopaminergic control of the striatum for high-level cognition. Curr Opin Neurobiol 2011;21:402-407.
112. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cereb Cortex 2009;19:445-454.
113. Rinne JO, Portin R, Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 2000;57:470-475.
114. Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 2009;15:88-93.
115. Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging 2005;26:891-898.
116. Bruck A, Portin R, Lindell A, et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 2001;311:81-84.
117. Carbon M, Ma Y, Barnes A, et al. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 2004;21:1497-1507.
118. Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol 2012;11:679-687.
119. Kato M, Miyashita N, Hikosaka O, Matsumura M, Usui S, Kori A. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades. J Neurosci 1995;15:912-927.
120. Kori A, Miyashita N, Kato M, Hikosaka O, Usui S, Matsumura M. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccades. J Neurosci 1995;15:928-941.
121. Noudoost B, Moore T. Control of visual cortical signals by prefrontal dopamine. Nature 2011;474:372-375.
122. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983;275:321-328.
123. Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev 2000;24:655-668.
124. Whitehouse PJ, Struble RG, Hedreen JC, et al. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacol Bull 1983;19:437-440.
125. Whitehouse PJ, Hedreen JC, White CL 3rd, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983;13:243-248.
126. Aubert I, Araujo DM, Cecyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem 1992;58:529-541.
127. Pimlott SL, Piggott M, Owens J, et al. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology 2004;29:108-116.
128. Schmaljohann J, Gundisch D, Minnerop M, et al. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease. Nucl Med Biol 2006;33:305-309.
129. Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745-1748.
130. Bohnen NI, Kaufer DI, Hendrickson R, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol 2006;253:242-247.
131. Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-2518.
132. Giladi N, Shabtai H, Gurevich T, Benbunan B, Anca M, Korczyn AD. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease. Acta Neurol Scand 2003;108:368-373.
133. Redgrave P, Prescott TJ, Gurney K. Is the short-latency dopamine response too short to signal reward error? Trends Neurosci 1999;22:146-151.
134. Joshua M, Adler A, Bergman H. The dynamics of dopamine in control of motor behavior. Curr Opin Neurobiol 2009;19:615-620.